NCT06408662 Remote Delivery of a Mindfulness-based Intervention for Tics
| NCT ID | NCT06408662 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Johns Hopkins University |
| Condition | Tourette Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2024-05-23 |
| Primary Completion | 2028-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2024-05-23 with a primary completion date of 2028-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research study is being done to compare a mindfulness-based intervention for tics (MBIT) to psychoeducation with relaxation and supportive therapy (PRST) for individuals with Tourette's syndrome or Persistent Tic Disorders (collectively TS). It is the investigator's hope that this information cam be used to improve current treatments for individuals with TS.
Eligibility Criteria
Inclusion Criteria: 1. be ≥18 years of age; 2. meet diagnostic criteria for a primary or co-primary diagnosis of Tourette Syndrome or a Persistent Motor or Vocal Tic Disorder on a structured clinical interview; 3. have moderate or greater tic severity as evidenced by a YGTSS Total Tic Score of \>14 (when motor and vocal tics are present) or \>10 (when only motor or vocal tics are present); 4. be medication free and/or on a stable dose of psychiatric medication 8 weeks prior to study participation; 5. be not engaged in psychotherapy for non-TS conditions and/or be on a stable course of therapy for 6 months prior to study participation 6. be fluent in English; 7. have access to a smart phone and/or tablet. Exclusion Criteria: 1. a current diagnosis of substance use disorder, psychosis, mania or another condition that requires another form of care; 2. severe current suicidal/homicidal ideation and/or self-injury requiring medical intervention; 3. concurrent psychotherapy for TS; 4. prior extensive experience with mindfulness and/or meditation.
Contact & Investigator
Joseph F McGuire, PhD
PRINCIPAL INVESTIGATOR
Johns Hopkins University
Frequently Asked Questions
Who can join the NCT06408662 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tourette Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06408662 currently recruiting?
Yes, NCT06408662 is actively recruiting participants. Contact the research team at mbit@jh.edu for enrollment information.
Where is the NCT06408662 trial being conducted?
This trial is being conducted at Baltimore, United States.
Who is sponsoring the NCT06408662 clinical trial?
NCT06408662 is sponsored by Johns Hopkins University. The principal investigator is Joseph F McGuire, PhD at Johns Hopkins University. The trial plans to enroll 150 participants.